Alzheimer's Disease
Showing NaN - NaN of 102
Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)
Completed
- Alzheimer's Disease
- Rosiglitazone Extended Release 2mg
- +3 more
-
Litchfield Park, Arizona
- +248 more
Oct 23, 2017
Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)
Terminated
- Alzheimer's Disease
- Rosiglitazone XR
-
Litchfield Park, Arizona
- +271 more
Oct 11, 2017
Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)
Alzheimer's Disease Trial in Canada, United States (rosiglitazone)
Completed
- Alzheimer's Disease
-
Litchfield Park, Arizona
- +6 more
Apr 18, 2017
Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)
Terminated
- Alzheimer's Disease
- Dementia
- Drug: EVP-6124
- Placebo
-
Phoenix, Arizona
- +81 more
May 2, 2016
Alzheimer's Disease Trial in United States (ACC-001 3 µg/ QS-21 50 µg, ACC-001 10 µg/ QS-21 50 µg, Placebo- Phosphate buffered
Completed
- Alzheimer's Disease
- ACC-001 3 μg/ QS-21 50 μg
- +2 more
-
Phoenix, Arizona
- +39 more
Jan 28, 2016
CHF, Diabetes, Coronary Artery Disease Trial in United States (Care Coordination)
Unknown status
- Congestive Heart Failure
- +8 more
- Care Coordination
-
Phoenix, Arizona
- +14 more
Sep 29, 2015
Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)
Alzheimer's Disease Trial in United States (DHA (Docosahexaenoic Acid), Placebo)
Completed
- Alzheimer's Disease
- DHA (Docosahexaenoic Acid)
- Placebo
-
Birmingham, Alabama
- +50 more
Sep 15, 2014